Summary: A mouse study finds that voluntary exercise boosts dopamine signaling in motor regions of the brain. These results offer a potential explanation for why physical activity can relieve motor symptoms in Parkinson’s disease.
Source: SfN
New research published in Journal of Neuroscience shows that regular voluntary exercise increases dopamine release in motor areas of the mouse brain. The study links this change to elevated levels of brain-derived neurotrophic factor (BDNF), suggesting a biological pathway through which exercise may improve motor function and potentially ease symptoms of neurodegenerative conditions such as Parkinson’s disease.
Exercise is widely recognized for its benefits to the brain: it can improve mood, support learning and memory, and reduce age-related cognitive decline. Clinically, people with Parkinson’s disease often experience improved motor performance after engaging in structured physical activity, but the cellular and molecular mechanisms underlying these improvements have remained unclear.
Dopamine is a critical neurotransmitter for both movement and emotional regulation, and its progressive loss is a hallmark of Parkinson’s disease. To explore whether exercise modifies dopamine signaling in motor regions, Bastioli and colleagues compared two groups of mice: one given free access to running wheels for 30 days and a sedentary control group that did not exercise.
The authors measured dopamine release in the striatum, a brain region that plays a central role in coordinating movement. In the mice that had been running, electrically evoked dopamine release in the striatum was significantly increased compared with sedentary animals. Importantly, this enhancement in dopamine signaling persisted for at least one week after the mice stopped exercising, indicating a lasting effect rather than a short-lived boost tied only to activity sessions.
Alongside changes in dopamine dynamics, the exercising mice showed higher levels of brain-derived neurotrophic factor (BDNF) in the striatum. BDNF is a protein that supports neuronal health, synaptic plasticity, and survival; it is often implicated in the beneficial effects of lifestyle interventions on the brain. To test whether BDNF was necessary for the exercise-related increase in dopamine release, the researchers repeated their experiments in a genetic mouse model that lacks BDNF. In those animals, exercise did not produce the same increase in striatal dopamine release, suggesting that BDNF is a key mediator of the exercise effect.
These findings indicate a plausible pathway: voluntary exercise elevates BDNF levels in motor circuitry, which in turn enhances dopamine signaling in the striatum. Enhanced dopamine release in motor areas could directly improve motor control and might account for some of the symptomatic benefits seen in people with movement disorders when they engage in physical activity.
The study raises several important questions for future research. The authors plan to determine whether the same relationship between exercise, BDNF, and dopamine signaling holds in mouse models that reproduce key features of Parkinson’s disease, including progressive loss of dopamine-producing neurons. They will also investigate whether exercise can lead to measurable improvements in motor outcomes in those disease models and whether similar mechanisms operate in humans.
Overall, this work strengthens the biological rationale for prescribing exercise as part of strategies to maintain motor function and brain health. By identifying BDNF as a catalytic factor for exercise-induced changes in dopamine signaling, the study points to potential targets for therapies that could amplify or mimic the benefits of physical activity for people with Parkinson’s disease and other movement disorders.
About this dopamine and exercise research news
Author: Calli McMurray
Source: SfN
Contact: Calli McMurray – SfN
Image: The image is in the public domain
Original Research: The findings will appear in Journal of Neuroscience